High-protein enteral feeds are estimated at 42.1% of formulation demand in 2026, with the acute ICU phase at 51.1% and enteral tube feeds at 39.1% of product form. Adoption follows early critical-care feeding protocols, while hemodynamic instability and tolerance limits restrict routine formula escalation.